{"transactions":[{"id":739605,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2026-06-12T11:42:03.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":50500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 10, 2027, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":50500,"derivative":{"exercise_price":3.99,"exercise_date":"2027-06-10","expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":50500},"source":{"system":"sec-edgar","filing":"0001214659-26-007394","document":"marketforms-73386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465926007394/marketforms-73386.xml","form_type":"4"}},{"id":1113182,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2025-06-12T13:57:23.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":3.41,"value":143220.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":42000,"derivative":{"exercise_price":3.41,"exercise_date":"2026-06-11","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":42000},"source":{"system":"sec-edgar","filing":"0001214659-25-009118","document":"marketforms-69475.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465925009118/marketforms-69475.xml","form_type":"4"}},{"id":1471923,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-06-21T13:51:17.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":38000,"derivative":{"exercise_price":2.5,"exercise_date":"2025-06-20","expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001214659-24-011220","document":"marketforms-66327.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465924011220/marketforms-66327.xml","form_type":"4"}},{"id":1845073,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2023-06-23T12:26:51.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 21, 2024, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.02,"exercise_date":"2024-06-21","expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-23-008795","document":"marketforms-61962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465923008795/marketforms-61962.xml","form_type":"4"}},{"id":2221934,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2022-06-24T16:22:57.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 22, 2023, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":25000,"derivative":{"exercise_price":0.7132,"exercise_date":"2023-06-22","expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001214659-22-008289","document":"marketforms-56518.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465922008289/marketforms-56518.xml","form_type":"4"}},{"id":2288871,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant","published_at":"2022-04-28T11:25:08.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on April 26, 2022, of 75,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $3.00 per share of common stock and accompanying warrant."}],"balance_after":75000,"derivative":{"exercise_price":3.45,"exercise_date":"2022-04-26","expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-025903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122025903/doc4.xml","form_type":"4"}},{"id":2288870,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-28T11:25:08.000Z","date":"2022-04-26","kind":"purchase","acquired":true,"shares":75000,"price":3,"value":225000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on April 26, 2022, of 75,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $3.00 per share of common stock and accompanying warrant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares purchased under the issuer's ESPP, which did not require the filing of a Form 4 for such purchase."}],"balance_after":272068,"source":{"system":"sec-edgar","filing":"0001209191-22-025903","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122025903/doc4.xml","form_type":"4"}},{"id":2408719,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-08T21:14:38.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":232000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":232000,"derivative":{"exercise_price":4.6,"expiration_date":"2032-02-03","underlying":"Common Stock","underlying_shares":232000},"source":{"system":"sec-edgar","filing":"0001209191-22-007735","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122007735/doc4.xml","form_type":"4"}},{"id":2408718,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-08T21:14:38.000Z","date":"2022-02-04","kind":"grant","acquired":true,"shares":87200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest 50% per year over two years on the anniversary of the date of grant."}],"balance_after":196968,"source":{"system":"sec-edgar","filing":"0001209191-22-007735","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919122007735/doc4.xml","form_type":"4"}},{"id":2663431,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Purchase)","published_at":"2021-06-17T18:51:37.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest as follows: 100% of the underlying shares vest June 15, 2022, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date."}],"balance_after":20000,"derivative":{"exercise_price":4.04,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001214659-21-006720","document":"marketforms-53153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465921006720/marketforms-53153.xml","form_type":"4"}},{"id":2789063,"issuer":{"id":5276,"kind":"organization","name":"Aquestive Therapeutics, Inc.","symbol":"AQST"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-15T17:10:35.000Z","date":"2021-03-11","kind":"grant","acquired":true,"shares":28500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 11, 2022."}],"balance_after":28500,"derivative":{"exercise_price":5.3,"expiration_date":"2031-03-11","underlying":"Common Stock","underlying_shares":28500},"source":{"system":"sec-edgar","filing":"0001214659-21-003149","document":"marketforms-51885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1408870/000121465921003149/marketforms-51885.xml","form_type":"4"}},{"id":2886210,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-02T21:03:23.000Z","date":"2021-01-29","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":170000,"derivative":{"exercise_price":7.47,"expiration_date":"2031-01-28","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0001209191-21-006718","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919121006718/doc4.xml","form_type":"4"}},{"id":2933318,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:10:50.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":20000,"derivative":{"exercise_price":8.25,"exercise_date":"2020-12-21","expiration_date":"2024-06-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-064960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064960/doc4.xml","form_type":"4"}},{"id":2933317,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant","published_at":"2020-12-23T14:10:50.000Z","date":"2020-12-21","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":20000,"derivative":{"exercise_price":7.33,"exercise_date":"2020-12-21","expiration_date":"2021-12-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-20-064960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064960/doc4.xml","form_type":"4"}},{"id":2933316,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-12-23T14:10:50.000Z","date":"2020-12-21","kind":"purchase","acquired":true,"shares":40000,"price":6.25,"value":250000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 21, 2020 of 40,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $6.25 per share of common stock and accompanying warrants to purchase 0.50 of a share of common stock (Series 1 warrant) and 0.50 of a share of common stock (Series 2 warrant)."}],"balance_after":109668,"source":{"system":"sec-edgar","filing":"0001209191-20-064960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120064960/doc4.xml","form_type":"4"}},{"id":3157173,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2020-05-08T23:14:44.000Z","date":"2020-05-08","kind":"exercise","acquired":false,"shares":60,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the \"Stated Value\").  On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the \"Stated Value\").  On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the \"Stated Value\").  On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the \"Stated Value\").  On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0000899243-20-012457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924320012457/doc4.xml","form_type":"4"}},{"id":3157172,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T23:14:44.000Z","date":"2020-05-08","kind":"exercise","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Series E Convertible Preferred Stock has no expiration date and a stated value of $1,000 (the \"Stated Value\").  On May 8, 2020, reporting person converted the Series E Preferred Stock into that number of shares of Delcath Systems Inc. common stock determined by dividing the Stated Value by the conversion price of $10.00."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects a one-for-seven hundred (1:700) reverse stock split effected on December 24, 2019."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0000899243-20-012457","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924320012457/doc4.xml","form_type":"4"}},{"id":3292105,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-04T21:02:25.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":900000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":900000,"derivative":{"exercise_price":0.863,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":900000},"source":{"system":"sec-edgar","filing":"0001209191-20-006266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919120006266/doc4.xml","form_type":"4"}},{"id":3341106,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant  (right to buy)","published_at":"2019-12-16T20:10:19.000Z","date":"2019-12-12","kind":"purchase","acquired":true,"shares":166667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The warrant expires on the earlier of (i) such date that is six months after the issuer publicly announces the approval from the U.S. Food and Drug Administration for ibrexafungerp for the treatment of vulvovaginal candidiasis and (ii) June 12, 2023."}],"balance_after":166667,"derivative":{"exercise_price":1.1,"exercise_date":"2019-12-12","underlying":"Common Stock","underlying_shares":166667},"source":{"system":"sec-edgar","filing":"0001209191-19-060615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119060615/doc4.xml","form_type":"4"}},{"id":3341105,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-12-16T20:10:19.000Z","date":"2019-12-12","kind":"purchase","acquired":true,"shares":166667,"price":0.9,"value":150000.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant."}],"balance_after":693682,"source":{"system":"sec-edgar","filing":"0001209191-19-060615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119060615/doc4.xml","form_type":"4"}},{"id":3431254,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-22T12:22:10.000Z","date":"2019-08-21","kind":"purchase","acquired":true,"shares":9500,"price":1.11,"value":10545.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.11 to $1.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":526015,"source":{"system":"sec-edgar","filing":"0001209191-19-047071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119047071/doc4.xml","form_type":"4"}},{"id":3431253,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-22T12:22:10.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"shares":500,"price":1.11,"value":555.0,"ownership":{"direct":true},"balance_after":516515,"source":{"system":"sec-edgar","filing":"0001209191-19-047071","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119047071/doc4.xml","form_type":"4"}},{"id":3434703,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-19T12:31:38.000Z","date":"2019-08-15","kind":"purchase","acquired":true,"shares":10015,"price":1.01,"value":10115.15,"ownership":{"direct":true},"balance_after":516015,"source":{"system":"sec-edgar","filing":"0001209191-19-046455","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119046455/doc4.xml","form_type":"4"}},{"id":3455623,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrant (Right to Buy)","published_at":"2019-07-27T01:28:06.000Z","date":"2019-07-15","kind":"purchase","acquired":true,"shares":1000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The purchase was made in a private (PIPE) transaction with the issuer in which the issuer sold Series E Convertible Preferred Stock and warrants. The transactions contemplated by the PIPE transaction were reported on a current report on Form 8-K filed with the SEC by the issuer on each of July 11, 2019 and July 22, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split."}],"balance_after":1000000,"derivative":{"exercise_price":0.06,"underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-19-020491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924319020491/doc4.xml","form_type":"4"}},{"id":3455622,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2019-07-27T01:28:06.000Z","date":"2019-07-15","kind":"purchase","acquired":true,"shares":60,"price":1000,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Series E Convertible Preferred Stock, par value of $0.01 per share, has a stated value of $1,000 (the \"Stated Value\") and is convertible at any time at the option of the holder into the number of shares of Delcath common stock determined by dividing the Stated Value by the conversion price of $0.06, subject to certain limitations and adjustments contemplated within the Certificate of Designation."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The purchase was made in a private (PIPE) transaction with the issuer in which the issuer sold Series E Convertible Preferred Stock and warrants. The transactions contemplated by the PIPE transaction were reported on a current report on Form 8-K filed with the SEC by the issuer on each of July 11, 2019 and July 22, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Series E Convertible Preferred Stock, par value of $0.01 per share, has a stated value of $1,000 (the \"Stated Value\") and is convertible at any time at the option of the holder into the number of shares of Delcath common stock determined by dividing the Stated Value by the conversion price of $0.06, subject to certain limitations and adjustments contemplated within the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series E Convertible Preferred Stock has no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The warrant was included together with the purchase of Series E Convertible Preferred Stock purchased by the reporting person for $1,000 per share. The purchase of shares of Series E Convertible Preferred Stock was accompanied by a right to purchase 16,666.67 shares of common stock for an aggregate of 1,000,000 shares of common stock. The exercise price of each share under the warrant is $0.06, subject to adjustment in accordance with the terms of the warrant and is exercisable at any time from the date that the issuer effects a reverse stock split through 5:00 p.m. (NYC time) on the fifth anniversary of the date of the reverse stock split."}],"balance_after":60,"derivative":{"exercise_price":0.06,"underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-19-020491","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924319020491/doc4.xml","form_type":"4"}},{"id":3552821,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-18T12:39:33.000Z","date":"2019-04-17","kind":"purchase","acquired":true,"shares":25000,"price":1.63,"value":40750.0,"ownership":{"direct":true},"balance_after":506000,"source":{"system":"sec-edgar","filing":"0001209191-19-025201","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119025201/doc4.xml","form_type":"4"}},{"id":3650330,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-19T21:54:05.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":700000,"derivative":{"exercise_price":1.38,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001209191-19-011129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119011129/doc4.xml","form_type":"4"}},{"id":3675708,"issuer":{"id":5387,"kind":"organization","name":"DELCATH SYSTEMS, INC.","symbol":"DCTH"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-02-06T02:02:49.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in equal amounts of 8,333 options for 11 consecutive months commencing on the one month anniversary of the grant date, and the balance of the options (8,337) vesting on the 12 month anniversary of the grant date.  Options are immediately exercisable upon vesting."}],"balance_after":100000,"derivative":{"exercise_price":0.281,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-19-002728","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872912/000089924319002728/doc4.xml","form_type":"4"}},{"id":3696537,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-14T14:04:38.000Z","date":"2019-01-10","kind":"purchase","acquired":true,"shares":25000,"price":0.69,"value":17250.0,"ownership":{"direct":true},"balance_after":480000,"source":{"system":"sec-edgar","filing":"0001209191-19-003517","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119003517/doc4.xml","form_type":"4"}},{"id":3713555,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2019-01-02T16:28:44.000Z","date":"2018-12-31","kind":"purchase","acquired":true,"shares":25000,"price":0.46,"value":11500.0,"ownership":{"direct":true},"balance_after":455000,"source":{"system":"sec-edgar","filing":"0001209191-19-000039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919119000039/doc4.xml","form_type":"4"}},{"id":3832919,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-27T12:29:17.000Z","date":"2018-08-23","kind":"purchase","acquired":true,"shares":25000,"price":1.29,"value":32250.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.26 to $1.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":429000,"source":{"system":"sec-edgar","filing":"0001209191-18-048444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118048444/doc4.xml","form_type":"4"}},{"id":4001223,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2018-03-12T12:50:54.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":45000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":45000,"derivative":{"exercise_price":2,"exercise_date":"2018-03-08","expiration_date":"2023-03-08","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-18-018708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018708/doc4.xml","form_type":"4"}},{"id":4001222,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Warrant (right to buy)","published_at":"2018-03-12T12:50:54.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":75000,"derivative":{"exercise_price":1.85,"exercise_date":"2018-03-08","expiration_date":"2019-03-14","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-18-018708","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018708/doc4.xml","form_type":"4"}},{"id":4001221,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-12T12:50:54.000Z","date":"2018-03-08","kind":"purchase","acquired":true,"shares":100000,"price":1.69,"value":169000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the purchase on March 8, 2018, of 100,000 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant)."}],"balance_after":404000,"source":{"system":"sec-edgar","filing":"0001209191-18-018708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118018708/doc4.xml","form_type":"4"}},{"id":4063072,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-02-13T22:04:33.000Z","date":"2018-02-09","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":375000,"derivative":{"exercise_price":1.69,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001209191-18-009630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000120919118009630/doc4.xml","form_type":"4"}},{"id":4202565,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-09-25T20:34:32.000Z","date":"2017-09-22","kind":"purchase","acquired":true,"shares":10000,"price":2.23,"value":22300.0,"ownership":{"direct":true},"balance_after":303000,"source":{"system":"sec-edgar","filing":"0001178253-17-000020","document":"wf-form4_150637165803274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000020/wf-form4_150637165803274.xml","form_type":"4"}},{"id":4225649,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-24T13:28:56.000Z","date":"2017-08-23","kind":"purchase","acquired":true,"shares":4993,"price":1.85,"value":9237.05,"ownership":{"direct":true},"balance_after":292000,"source":{"system":"sec-edgar","filing":"0001178253-17-000019","document":"wf-form4_150358132152635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000019/wf-form4_150358132152635.xml","form_type":"4"}},{"id":4225648,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-24T13:28:56.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":7,"price":1.61,"value":11.27,"ownership":{"direct":true},"balance_after":287007,"source":{"system":"sec-edgar","filing":"0001178253-17-000019","document":"wf-form4_150358132152635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000019/wf-form4_150358132152635.xml","form_type":"4"}},{"id":4230963,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-17T13:32:19.000Z","date":"2017-08-15","kind":"purchase","acquired":true,"shares":10000,"price":1.61,"value":16100.0,"ownership":{"direct":true},"balance_after":287000,"source":{"system":"sec-edgar","filing":"0001178253-17-000018","document":"wf-form4_150297672592049.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000018/wf-form4_150297672592049.xml","form_type":"4"}},{"id":4321041,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-15T12:17:54.000Z","date":"2017-05-12","kind":"purchase","acquired":true,"shares":25000,"price":1.69,"value":42250.0,"ownership":{"direct":true},"balance_after":277000,"source":{"system":"sec-edgar","filing":"0001178253-17-000009","document":"wf-form4_149485065910342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000117825317000009/wf-form4_149485065910342.xml","form_type":"4"}},{"id":4471277,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-02T19:23:30.000Z","date":"2017-01-31","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2.08% of the shares subject to the option vest monthly for 48 months as measured from the date of grant."}],"balance_after":360000,"derivative":{"exercise_price":3.02,"expiration_date":"2027-01-31","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001628280-17-000755","document":"wf-form4_148606339727714.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000162828017000755/wf-form4_148606339727714.xml","form_type":"4"}},{"id":4513406,"issuer":{"id":7194,"kind":"organization","name":"SCYNEXIS INC","symbol":"SCYX"},"owners":[{"id":38684,"kind":"person","name":"Taglietti Marco","position":1,"cik":"0001408870","reported_name":"Taglietti Marco","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-12-22T11:05:34.000Z","date":"2016-12-21","kind":"purchase","acquired":true,"shares":25000,"price":3.3,"value":82500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.28 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":251000,"source":{"system":"sec-edgar","filing":"0001628280-16-022131","document":"wf-form4_148240472143546.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178253/000162828016022131/wf-form4_148240472143546.xml","form_type":"4"}}]}